Debts
€3.2m 93% of the balance sheet
Financial debts 25%Suppliers 47%Taxes and wages 9%Other 19%
€883,056 of the debts are secured on the company's own assets. In 2021 that was €1.8m.
Europhar
Lifetime
20 annual accounts with figures on one time axis, 27 filings since 1999peak €1.6m (2025)
€1.6m▲ 3.7%
lowest -€144,909 (2018)
€242,204▲ 20.2%
peak €282,121 (2014)
€230,230▲ €242,204
€3.2m▼ 2.5%
peak 16.3 FTE (2024)
16.1 FTE▼ 1.2%
Board11 names since 2018
3 directorsBLUESTONE and 2 others
Owners
Documentsfilings and deeds
31-08-202631 days late
2025financial year
Equity from -€11,974 to €230,230Cash from €110,975 to €242,060
Key points
from the 2025 annual accountsInvestments
€48,102 0.2 × depreciation
Green is investment, beige is depreciation.
Staff
17 employees on 31-12-2025
In 2025, 2 people joined and 4 left.
Filings
27 annual accounts since 1999
Nine of the last ten came late. The 2019 accounts came latest: 159 days after the end of the period.
Board
1 joined · 1 left
Board changed. Latest change 22-09-2026 · 3 in office.
Position in the sector
6.6%
Lower solvency than 89% of companies in wholesale trade. Sector median 45.2% · 6,192 companies.
Checked score
81
Excellent
Financially stronger than 50% of small companies in wholesale trade (NACE 46)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 4,374 companies (NACE 46, small).
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 9.9%highest value
01-2025: 4.9%▼ -5.0 percentage points vs 12-2024
02-2025: 5.0%▲ +0.1 percentage points vs 01-2025
03-2025: 5.5%▲ +0.5 percentage points vs 02-2025
04-2025: 5.6%▲ +0.1 percentage points vs 03-2025
05-2025: 5.9%▲ +0.3 percentage points vs 04-2025
06-2025: 3.9%▼ -2.0 percentage points vs 05-2025
07-2025: 3.9%● unchanged vs 06-2025
08-2025: 4.7%▲ +0.8 percentage points vs 07-2025
09-2025: 5.0%▲ +0.3 percentage points vs 08-2025
10-2025: 1.2%▼ -3.8 percentage points vs 09-2025
11-2025: 1.2%● unchanged vs 10-2025
12-2025: 1.2%● unchanged vs 11-2025
01-2026: 1.2%● unchanged vs 12-2025
02-2026: 1.2%● unchanged vs 01-2026
03-2026: 1.4%▲ +0.2 percentage points vs 02-2026
04-2026: 1.3%▼ -0.1 percentage points vs 03-2026
05-2026: 1.4%▲ +0.1 percentage points vs 04-2026
06-2026: 1.4%● unchanged vs 05-2026
07-2026: 1.5%▲ +0.1 percentage points vs 06-2026
08-2026: 2.2%▲ +0.7 percentage points vs 07-2026
09-2026: 0.6%▼ -1.6 percentage points vs 08-2026lowest value
10-2026: 0.6%● unchanged vs 09-2026lowest value
11-2026: 0.6%● unchanged vs 10-2026lowest value
Financial strengthWeak
Score breakdown
raises risk
Equity €230,230 (6.6% of total assets)
Last filed accounts filed 31 days late; 2 of the last 3 accounts late
lowers risk
Founded in 1999
Figures for financial year 2025 (filed on 04-09-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small). It does better than 9% of them on solvency, 14% on liquidity, 77% on profitability and 99% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 496 companies had the same profile as Europhar has now. Each dot is one company, two years later.
95.6%
were still trading
3.2%
stopped another way
1.2%
went bankrupt
That fits the bankruptcy probability of Europhar itself: 0.6% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 496 companies, not a prediction for Europhar. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.67 (0.58 in 2024), below 1. Short-term debt is 76.6% and cash 7% of total assets. 93.4% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 11% of 6192 sector peers (2025).
NBB · sector comparisonPosition among 6192 sector peers
Solvency
better than 11%
← weakest
strongest →
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
31 days late
2024
29 days late
2023
138 days late
2022
100 days late
2021
36 days late
2020
80 days late
2019
159 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 82 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 5 September (4 of the last 5 accounts filed within 64 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
1 director appointed, 1 resignation
Resignation: PHARMAOACH · Permanent representatives: Paul RANSART and Stéphanie THOMAES · Appointment: PALATINE · General meeting of 08-09-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0465065411
Purpose change · Amendment of the articles
“Article 3. Objet” (deed in French) · General meeting of 28-12-2023 · Gazette deed
Registered office moved within Genappe
New registered office: Rue des Lilas 1, 1470 Genappe · Previous registered office: Rue Godefroid de Bouillon 32, 1470 Genappe · Resignations: Patrick WERA, Valérie WERA, Florence WERA, Hélène WERA and Pierre WERA · General meeting of 28-04-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Europhar Genappe | €3.5m | €1.6m | 6.6% | 16.1 |
| AB-TECHNICS Malle | €2.9m | €1.3m | 29.1% | 17.1 |
| LPG BENELUX Drogenbos | €3.5m | €1.2m | -46.7% | 17.2 |
| TELEMIS Ottignies-Louvain-la-Neuve | €4.3m | €2.7m | 22.2% | 21.2 |
| ASTEL MEDICA Neupré | €2.6m | €2.1m | 53.2% | 14.6 |
| F CARE SYSTEMS Antwerp | €3.1m | €1.3m | 52.9% | 11.7 |
| LABORATOIRES EXPANSCIENCE BELGIUM Asse | €3.2m | €2.3m | 37.3% | 20.4 |
These companies have the same main activity as Europhar: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €2.6m and €4.3m, founded between 1995 and 2000.
Official details
Source: KBO- Status
- Active since 08-01-1999Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment units
- 2.092.824.1911470 Genappe, since 16-11-1999
- 2.255.498.3395060 Sambreville, since 20-06-2016
- Financial year end
- 31 December
- Peppol
- Reachable since 29-12-2025
Annual accounts 2025
- ≈ €6.5mestimated
- €3.5m▲ 4.8%
- Employeeson 31-12-2025
- 17▼ 10.5%
- Filing
- Filed on 31-08-2026
Insights on Europhar
Europhar has existed since 1999. In 2010 the gross margin rose from €188,293 to €400,904 and staff from 2.7 to 3.6 full-time equivalents.
The gross margin has grown every year since 2021. Solvency rose in 2025 from -0.4% to 6.6% because of the retained profit.
PALATINE holds all the shares. In May 2023, five directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Europhar
- What is the company number of Europhar?
- The company number of Europhar is 0465.065.411. The VAT number is the same number with BE in front: BE 0465.065.411.
- Where is Europhar based?
- The registered office is at Rue des Lilas 1, 1470 Genappe.Company details
- What does Europhar do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of Europhar?
- Europhar is a public limited company (NV).
- When was Europhar founded?
- Europhar was founded on 08-01-1999.
- Is Europhar still active?
- Yes, Europhar is an active enterprise in the KBO register.
- How many employees does Europhar have?
- Europhar had an average of 16.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Europhar fall under?
- In its 2025 annual accounts, Europhar states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of Europhar?
- The turnover in financial year 2025 is ≈ €6.5m. This figure is estimated from the gross margin of €1.6m and 98 comparable companies (NACE 46). It probably lies between €3.9m and €11.0m. In financial year 2019 turnover was €5.1m.
- Is Europhar profitable?
- In financial year 2025, Europhar made a profit of €242,204.
- Where can I find the annual accounts of Europhar?
- Europhar filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Europhar due?
- Europhar must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.BLUESTONE · 15 companies
See how customers, suppliers and banks see your own company and what to improve first.